(888) 552-6760 SCHEDULE AN APPOINTMENT

Thanh H. Dellinger,

M.D.

Gynecologic Oncologist

Biography photo
Location
City of Hope Duarte
1500 East Duarte Road
Duarte, CA 91010
Specialties
Gynecologic Oncology
Surgery
Education
Medical school:
Board Certifications
  • 2014-2022, Diplomate of the American Board of Obstetrics and Gynecology

Degrees
  • 2004, M.D., University of California Irvine School of Medicine, Irvine, CA

  • 1999, B.S., Biochemistry/Chemistry, University of California San Diego, La Jolla, CA

Fellowship
  • 2010-2012, Clinical Fellowship in Gynecological Oncology, UCI Medical Center, University of California Irvine, Orange, CA

  • 2008-2010, Research Fellowship in Gynecological Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, CA

Residency
  • 2004-2008, Residency, Obstetrics & Gynecology, Penn State University, Milton S. Hershey Medical Center, Hershey, PA

Professional Experience
  • 2020-present, Associate Professor, Division of Gynecologic Oncology, Department of Surgery, City of Hope, Duarte, CA

  • 2012-2020, Assistant Professor, Division of Gynecologic Oncology, Department of Surgery, City of Hope, Duarte, CA

  • 2008- 2012, Clinical Instructor, Department of Obstetrics and Gynecology, University of California Irvine Medical Center, Irvine, CA

Academic Appointments
  • Associate Professor, Division of Gynecologic Oncology, Department of Surgery
About Me

Thanh Dellinger, M.D., is a gynecologic oncologist at City of Hope® Cancer Center Duarte

Dr. Dellinger is an expert in leading-edge surgical techniques for treating conditions including uterine, ovarian and cervical cancer, including robotic surgery for cervical and uterine cancers, as well as advanced cytoreductive surgery for ovarian cancer. These procedures are safe, effective and can promote faster recovery and better outcomes than conventional surgery while also minimizing scarring. She is also trained at administering PIPAC, a new method of delivering chemotherapy into the peritoneum, and is leading the first American clinical trial related to this therapy. 

A seasoned researcher, Dr. Dellinger has published more than 50 peer-reviewed articles covering topics such as PIPAC, HIPEC and molecular pathways in ovarian and uterine cancer. She earned her medical degree at University of California, Irvine, then completed her residency at Penn State University in University Park, Pennsylvania, and a fellowship in gynecologic oncology at the University of California, Irvine Medical Center.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.